• A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport
• A case of Hartnup disease
• A clinicobiochemical study of tryptophan and other plasma and urinary amino acids in the family with Hartnup disease
• A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder
• A protein complex in the brush-border membrane explains a Hartnup disorder allele
• ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition
• ACE2 and gut amino acid transport
• Acrodermatitis enteropathica-like eruptions in a child with Hartnup disease
• Adult-onset Hartnup disease presenting with neuropsychiatric symptoms but without skin lesions
• Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1
• Amino acids in cerebrospinal fluid and plasma: its usefulness in the study of neuropaediatric diseases
• Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin
• Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis
• Apical transporters for neutral amino acids: physiology and pathophysiology
• Association of celiac disease and Hartnup's disease? Value of the tryptophan loading test
• Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study
• Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
• Ataxia
• Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease
• Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester
• Clinical picture of Hartnup disease. Without urine amino acids or any other identified metabolic disorder (a new entity)
• Clinical studies of pediatric malabsorption syndromes
• Collectrin and ACE2 in renal and intestinal amino acid transport
• Complementation analysis demonstrates that insulin cross-links both alpha subunits in a truncated insulin receptor dimer
• COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption
• Disorders of renal tubular transport of amino acids, hexose and phosphate
• Dynamic study of plasma and urine amino acid patterns after an oral load of tryptophan. Application to a patient with a complex deficiency syndrome
• Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches
• Further evidence for allelic heterogeneity in Hartnup disorder
• Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse
• Hartnup disease
• Hartnup disease
• Hartnup disease
• Hartnup Disease
• Hartnup Disease
• Hartnup disease (report of 2 cases in one family)
• Hartnup disease is related to a mutation in the SL C6A19 gene coding for the B degrees AT1 aminoacid transporter
• Hartnup disease masked by kwashiorkor
• Hartnup disease presenting as hereditary spastic paraplegia and severe peripheral neuropathy
• Hartnup disease presenting in an adult
• Hartnup disease: MR findings
• Hartnup disorder
• Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19
• Hartnup disorder: Pathogenesis, pathophysiology, and therapy
• Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5
• Hartnup disorder: unraveling the mystery
• Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinico-pathological case study
• Hartnup syndrome. A rare metabolic disease
• Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder
• Identification and Characterization of Inhibitors of a Neutral Amino Acid Transporter, SLC6A19, Using Two Functional Cell-Based Assays
• Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse
• Inborn errors of metabolism
• Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention
• Indicanuria
• Influenza vaccination strategies for 2020-21 in the context of COVID-19
• Inherited amino acid transport disorders
• Intermittent dystonia in Hartnup disease
• Julius Caesar and the Julian emperors. A family cluster with Hartnup disease?
• Kidney tubular amino acid transport disorders
• Loss of CLTRN function produces a neuropsychiatric disorder and a biochemical phenotype that mimics Hartnup disease
• Massachusetts Metabolic Disorders Screening Program: III. Sarcosinemia
• Maternal Hartnup disorder
• Metabolic correlates of learning disability
• Metabolic diseases and the skin
• Metabolic syndromes with dermatologic manifestations
• Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder
• MR imaging of the lungs with hyperpolarized helium-3 gas transported by air
• Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases
• Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder
• Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors
• Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder
• New aspects for the brain in Hartnup disease based on mining of high-resolution cellular mRNA expression data for SLC6A19
• Nicotinic acid and nicotinamide
• Novel mutation in SLC6A19 causing late-onset seizures in Hartnup disorder
• Nutrient-gene interactions: the gene is not the disease and vice versa
• Occurrences of methylmalonic aciduria and Hartnup disorder in the same family
• Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra
• Persistence of the common Hartnup disease D173N allele in populations of European origin
• Photosensitivity and photodermatitis in childhood
• Photosensitivity in infants and children
• Pilot study of gas chromatographic-mass spectrometric screening of newborn urine for inborn errors of metabolism after treatment with urease
• Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules
• Rare mutations associating with serum creatinine and chronic kidney disease
• Renal tubule transport defect of amino acids
• SARS-CoV-2 Infectivity and Neurological Targets in the Brain
• Screening and identification of differential metabolites in serum and urine of bamaxiang pigs bitten by trimeresurus stejnegeri based on UPLC-Q-TOF/MS metabolomics technology
• Severe exfoliative erythema of malnutrition in a child with coexisting coeliac and Hartnup's disease
• Severe persistent unremitting dermatitis, chronic diarrhea and hypoalbuminemia in a child; Hartnup disease in setting of celiac disease
• Spontaneous scalp arteriovenous fistula in a child with hartnup disease
• Study of Seizure-Manifested Hartnup Disorder Case Induced By Novel Mutations in <em>SLC6A19</em>
• Study of Seizure-Manifested Hartnup Disorder Case Induced By Novel Mutations in SLC6A19
• Systemic tryptophan homeostasis
• The current concepts on the absorption of monosaccharides, amino acids and peptides in the mammalian small intestine
• The Hartnup phenotype: Mendelian transport disorder, multifactorial disease
• The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition
• Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations
• Toward a more rational field-genetic epidemiology
• Treatment of Hartnup disease with nicotinic acid
• Tryptophan and its metabolites in a family with Hartnup disease
• Use of ethyl esters of tryptophan to bypass the absorption defect in Hartnup disease